Gene Expression Profiles of the Immuno-Transcriptome in Equine Asthma.

Summary

# Editorial Summary: Gene Expression Profiles in Equine Asthma Equine asthma represents a significant clinical challenge, with mild (MEA) and severe (SEA) forms causing substantial morbidity, yet their underlying pathogenic mechanisms remain poorly characterised. Padoan and colleagues conducted a transcriptomic analysis of respiratory tract tissue from horses with MEA, SEA and healthy controls, examining differential gene expression patterns to elucidate how inflammatory responses differ between disease severities. The researchers identified distinct immunological signatures associated with each condition, revealing that SEA involves more pronounced upregulation of pro-inflammatory cytokine pathways and altered immune cell recruitment compared to MEA, with these molecular differences correlating directly to observable clinical manifestations such as airway remodelling and mucus production. These findings provide a molecular framework for understanding why SEA progresses beyond mild inflammation and suggest potential biomarkers that could support earlier diagnosis and severity stratification in clinical practice. For equine practitioners, this work underscores the biological distinction between MEA and SEA phenotypes and offers direction for developing targeted therapeutic interventions beyond current symptomatic management approaches.

Read the full abstract on PubMed

Key Findings

• •Gene expression profiling identified distinct immuno-transcriptome signatures differentiating MEA from SEA in the respiratory tract
• •Specific gene expression patterns in respiratory tissues correlate with clinical severity of equine asthma
• •Study provides molecular characterization of pathogenic mechanisms underlying equine airway inflammation

Conditions Studied

Tags